H. Lundbeck A/S | Ownership
Companies that own H. Lundbeck A/S
OppenheimerFunds, Inc.
4,202,524
2.11%
0
0.14%
03/31/2018
Norges Bank Investment Management
2,253,160
1.12%
1,040,788
0.02%
12/31/2017
Wellington Management Co. LLP
1,752,631
0.88%
-703,427
0.02%
07/31/2018
BlackRock Fund Advisors
1,742,023
0.88%
2,088
0.01%
09/06/2018
The Vanguard Group, Inc.
1,633,006
0.82%
50,700
0%
07/31/2018
Invesco Asset Management Deutschland GmbH
1,474,139
0.74%
507,913
0.75%
06/29/2018
APG Asset Management NV
834,452
0.42%
383,812
0.03%
03/31/2018
Acadian Asset Management LLC
819,283
0.41%
85,483
0.12%
08/31/2018
Deutsche Asset Management International GmbH
777,845
0.39%
-17,108
1.24%
07/31/2018
ATP Fondsmaeglerselskab A/S
646,032
0.32%
-551,604
0.39%
12/31/2017
| Address |
Ottiliavej 9
Valby CR 2500
Denmark
|
|
Employees
|
- |
| Website |
http://www.lundbeck.com |
| Updated |
07/08/2019 |
| H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets. |
